The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes
Open accessAbstract
The nano-complexes facilitated baicalin, antigen, and immunostimulant delivery to M2-like TAMs, which polarized and reversed the M2-like TAM phenotype and remodeled the tumor microenvironment to allow killing of tumor cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Macrophage Regulation of Tumor Responses to Anticancer Therapies
De Palma, M., & Lewis, C. E. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.013 · Cited by 1,079
Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment
Kim, J., & Bae, J.-S. (2016) · Mediators of Inflammation · doi:10.1155/2016/6058147 · Cited by 802
Radiation-Induced IFN-γ Production within the Tumor Microenvironment Influences Antitumor Immunity
Lugade, A. A., Sorensen, E. W., Gerber, S. A., Moran, J. P., Frelinger, J. G., & Lord, E. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3132 · Cited by 485
Sica, A., Saccani, A., Bottazzi, B., Polentarutti, N., Vecchi, A., Van Damme, J., & Mantovani, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.762 · Cited by 426
Macrophage polarization and plasticity in health and disease
Biswas, S. K., Chittezhath, M., Shalova, I. N., & Lim, J.-Y. (2012) · Immunologic Research · doi:10.1007/s12026-012-8291-9 · Cited by 394
Qian, Y., Qiao, S., Dai, Y., Xu, G., Dai, B., Lu, L., Yu, X., Luo, Q., & Zhang, Z. (2017) · ACS Nano · doi:10.1021/acsnano.7b05465 · Cited by 333
Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival
Cieslewicz, M., Tang, J., Yu, J. L., Cao, H., Zavaljevski, M., Motoyama, K., Lieber, A., Raines, E. W., & Pun, S. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312197110 · Cited by 314
Halama, N., Braun, M., Kahlert, C., Spille, A., Quack, C., Rahbari, N., Koch, M., Weitz, J., Kloor, M., Zoernig, I., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2173 · Cited by 300
Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages
Müller, E., Christopoulos, P. F., Halder, S., Lunde, A., Beraki, K., Speth, M., Øynebråten, I., & Corthay, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01383 · Cited by 239
Macrophage targeting: opening new possibilities for cancer immunotherapy
Cassetta, L., & Kitamura, T. (2018) · Immunology · doi:10.1111/imm.12976 · Cited by 166
Saeed, M., Gao, J. X., Shi, Y., Lammers, T., & Yu, H. (2019) · Theranostics · doi:10.7150/thno.37568 · Cited by 156
Macrophage mediated biomimetic delivery system for the treatment of lung metastasis of breast cancer
Fu, J., Wang, D., Mei, D., Zhang, H., Wang, Z., He, B., Dai, W., Zhang, H., Wang, X., & Zhang, Q. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.039 · Cited by 139
Self-citationHuang, Z. D., Yang, Y., Jiang, Y., Shao, J., Sun, X., Chen, J., Dong, L., & Zhang, J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.062 · Cited by 135
Huang, Z. D., Gan, J., Long, Z., Guo, G., Shi, X., Wang, C., Zang, Y., Ding, Z., Chen, J., Zhang, J., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.03.009 · Cited by 99
Zhang, Y., Wu, L., Li, Z., Zhang, W., Luo, F., Chu, Y., & Chen, G. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00305 · Cited by 99
Reversing the polarization of tumor-associated macrophages inhibits tumor metastasis
Yuan, R., Li, S., Geng, H., Wang, X., Guan, Q., Li, X., Ren, C., & Yuan, X. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.05.014 · Cited by 82
Nanomedicine engulfed by macrophages for targeted tumor therapy
Gu, Y., Li, S., Feng, S., Ding, L., Liu, Y., Zhu, Q., & Qian, Z. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s110146 · Cited by 76
Orzechowska, B., Chaber, R., Wiśniewska, A., Pajtasz‐Piasecka, E., Jatczak, B., Siemieniec, I., Gulanowski, B., Chybicka, A., & BŁACH-OLSZEWSKA, Z. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.10.005 · Cited by 68
Liu, Q., Jia, J., Yang, T., Fan, Q., Wang, L., & Ma, G. (2016) · Small · doi:10.1002/smll.201503662 · Cited by 62
Self-citationZhu, Y., Fang, J., Wang, H., Fei, M., Tang, T. F., Liu, K., Niu, W., & Zhou, Y. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s176403 · Cited by 59
Self-citationChoi, J., Sun, E. G., & Cho, S. (2019) · Chonnam Medical Journal · doi:10.4068/cmj.2019.55.1.31 · Cited by 51
Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep)
Ngambenjawong, C., Gustafson, H. H., Pineda, J. M., Kacherovsky, N. A., Cieslewicz, M., & Pun, S. H. (2016) · Theranostics · doi:10.7150/thno.15394 · Cited by 48
Role of TLR4 and TCR or BCR against baicalin-induced responses in T and B cells
Gong, S.-Q., Sun, W., Wang, M., & Fu, Y. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.09.015 · Cited by 28
Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity
Schettini, J. L., Kidiyoor, A., Besmer, D. M., Tinder, T. L., Roy, L. D., Lustgarten, J., Gendler, S. J., & Mukherjee, P. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1264-y · Cited by 27
Zhang, Q. H., Yuan, R., Li, X., Xu, T.-A., Zhang, Y., Yuan, X., Cui, Y., Shen, W., Guan, Q.-L., & Sun, X. (2017) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2017.2240 · Cited by 2
Cited by
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Guan, F., Wang, R., Yi, Z., Luo, P., Liu, W., Xie, Y., Liu, Z., Xia, Z., Zhang, H., & Cheng, Q. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02124-y · Cited by 371
Advancements in nanoparticle-based treatment approaches for skin cancer therapy
Zeng, L., Gowda, B. H. J., Ahmed, M. G., Abourehab, M. A. S., Chen, Z.-S., Zhang, C., Li, J., & Kesharwani, P. (2023) · Molecular Cancer · doi:10.1186/s12943-022-01708-4 · Cited by 365
Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies
Kumari, N., & Choi, S. H. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02272-x · Cited by 315
Metadata
- Authors
- Han, S., Wang, W., Wang, S., Yang, T., Zhang, G., Wang, D., Ju, R., Lu, Y., Wang, H., & Wang, L.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2021
- Volume
- 11
- Issue
- 6
- Pages
- 2892-2916
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W3119067764
- Cited by
- 271
- References
- 29
- FWCI
- 11.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.